RxDoctor Payments DataLook up a doctor →

Jeffrey Moses, MD

Interventional Cardiology · New York, NYNPI 1447369368

Payments from drug & device makers

$949,202in general payments, 2019–2025

Across 765 payments — averaging $1240.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$523K
  • Abbott$150K
  • Abiomed$108K
  • Shockwave Medical, Inc$78K
  • Philips North America LLC$28K
  • Medtronic$28K
  • plus $33K from 28 others
$319in research payments, 2019–2025

Across 5 payments — averaging $63.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$319

What the payments were for

  • Consulting fees$43,80018%
  • Speaking & faculty fees$85,96836%
  • Travel & lodging$58,76125%
  • Food & beverage$37,27016%
  • Entertainment$1820%
  • Ownership interest$12,4975%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific180$523,322
Abbott174$149,720
Abiomed97$108,181
Shockwave Medical, Inc24$78,315
Philips North America LLC30$28,442
Medtronic(2 entities)112$28,417
Siemens Medical Solutions USA, Inc.36$10,350
Verge Medical, Inc.1$8,500
Cardiovascular Systems Inc.24$6,203
Edwards Lifesciences21$2,433
Teleflex LLC6$710
Cathworks, Inc.3$590
Opsens Inc.4$503
GE HealthCare4$482
Biotronik Inc.6$310
Recor Medical Inc4$303
Asahi Intecc USA, Inc.4$302
Spectrawave, Inc2$286
ZOLL Circulation Inc1$239
W. L. Gore & Associates, Inc.4$229
AstraZeneca4$196
Myocardial Solutions, Inc.1$173
Heartflow, Inc.2$168
Boehringer Ingelheim8$154
Ancora Heart, Inc.1$146
Cardiva Medical, Inc.2$135
Johnson & Johnson1$124
Arrow International, Inc.2$96
Angiodynamics, Inc.1$47
Amgen2$40
Bridgebio Pharma, Inc.1$27
Cordis US CORP.1$21
Impulse Dynamics (USA) Inc.1$21
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$949,202 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$126,913
Medicare patients
130
Services billed
597

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium11$281

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →